Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Meyers Michael L. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 4 Meyers Michael L. (Director) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
10/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2022 4 Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Exercised 5,900 options to buy @ $8.77, valued at $51.7k
04/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2019 4 Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Bought 1,000 shares @ $4.93, valued at $4.9k
Bought 104 shares @ $4.87, valued at $506.5
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/07/2018 4 Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Bought 200 shares @ $4.79, valued at $958
03/05/2018 4 Meyers Michael L. (SVP, Chief Medical Officer) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 75,000 options to buy @ $9.4, valued at $705k
02/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy